MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Age at onset and Parkinson’s disease progression

    G. D'Urso, K. Taylor, T. Kustermann, N. Pavese, G. Pagano (Basel, Switzerland)

    Objective: Explore whether age at onset of Parkinson’s disease influences the rate of early disease progression. Background: In cross-sectional studies, older age at onset has…
  • MDS Virtual Congress 2020

    An Apparent Cluster of Parkinson’s Disease (PD) in a Golf Community

    J. Nutt, A. Zajack, J. Sandsness, V. Palmer, C. Meng, C. Tanner, P. Spencer (Portland, OR, USA)

    Objective: Objective: To describe an apparent cluster of PD in a golf community Background: Golf courses may use more pesticides/acre than are employed in agriculture. Certain…
  • MDS Virtual Congress 2020

    Movement disorders in a family carrying ATP7A variant

    G. Buongarzone, B. Minafra, E. Errichiello, S. Gana, A. Asaro, I. Canavero, E. Tartara, M. Paoletti, R. Zangaglia, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report an early onset parkinsonism in a family carrying a pathogenic variant in the ATP7A gene. Background: ATP7A variants cause Menkes disease (MD), a…
  • MDS Virtual Congress 2020

    HD Constellation: A novel patient-centred approach to enriching clinical datasets by combining medical record chart review and Enroll-HD

    K. Belendiuk, J.P Sacksteder, X. Sanii, E. Neacy, J. Levey, E. Korner, R. Houghton, G. Yohrling (South San Francisco, CA, USA)

    Objective: HD Constellation aims to create a dataset providing a longitudinal view of the Huntington’s disease (HD) course, based on physician-provided medical records in the…
  • MDS Virtual Congress 2020

    Pridopidine for the Treatment of Early Huntington’s Disease

    M. Geva, R. Reilmann, C. Olanow, M. Leinonen, Y. Cohen, P. Meyer, A. McGarry, O. Sabri, M. Hayden, K. Kieburtz (Herzliya, Israel)

    Objective: Assess the efficacy of pridopidine 45 mg bid for maintenance of total functional capacity (TFC) and motor function in early HD patients. Background: Pridopidine…
  • MDS Virtual Congress 2020

    The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntington’s disease pathogenesis

    S. Xu, G. Li, X. Ye, L. Ye, Z. Xu, E. Furr Stimming, S. Zhang (Houston, TX, USA)

    Objective: Huntington’s disease (HD) is caused by an abnormal expansion of a glutamine tract (polyQ) in huntingtin (HTT), a large scaffold protein with numerous reported…
  • MDS Virtual Congress 2020

    The usefulness of a dual-phase 18-F-FP-CIT PET in a case of Alzheimer’s disease with slow movement

    WW. Lee (Seoul, Republic of Korea)

    Objective: To think about the usefulness of a dual-phase 18-F-FP-CIT PET in cases of dementia with bradykinesia. Background: A classic 18-F-FP-CIT PET is useful in…
  • MDS Virtual Congress 2020

    Preclinical pharmacology and early clinical development of dopamine D1 positive allosteric modulators (D1PAMs) with therapeutic potential for neuropsychiatric disorders

    K. Svensson, H. Meltzer, K. Biglan (Indianapolis, IN, USA)

    Objective: The objective was to characterize novel dopamine D1PAMs pre-clinically in behavioral and neurochemical models and in phase 1 human studies in healthy volunteers and…
  • MDS Virtual Congress 2020

    Associations between balance confidence, gait, postural stability, and muscle strength in people with Parkinson’s disease

    B. Donmez Colakoglu, F.K Cekok, T. Kahraman, G. Duran, D. Yerlikaya, G. Yener, A. Genc (Izmir, Turkey)

    Objective: This study aimed to investigate the associations between balance confidence and gait difficulty, postural instability, and muscle weakness in people with Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador

    J. Lopez-Castellanos, J. Lopez Contreras (Little Rock, AR, USA)

    Objective: To Evaluate the therapeutic and preventive effect of OnabotulinumtoxinA in the treatment of trigeminal neuralgia (TN) and chronic migraine (CM) in patients with bilateral…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley